Nomad Power Solutions (NMAD) Operating Expenses (2010 - 2026)
Nomad Power Solutions (NMAD) posted Operating Expenses of $2.3 million for Q2 2026, up 28.8% on a QoQ basis from $1.8 million in Q4 2025, and up 203.29% year-over-year from $774809.0 in Q2 2025.
Analysis
Nomad Power Solutions (NMAD) Operating Expenses (2010 - 2026) Analysis & Trends
Nomad Power Solutions has reported Operating Expenses for 17 years, with the latest figure at $2.3 million in Q2 2026.
- On a quarterly basis, Operating Expenses rose 203.29% year-over-year to $2.3 million in Q2 2026; TTM through Jun 2026 was $6.8 million, a 119.28% increase from a year earlier, with the FY2025 full-year figure at $5.1 million, up 42.96% from the prior year.
- Operating Expenses was $2.3 million for Q2 2026 at Nomad Power Solutions, up from $1.8 million in the prior quarter.
- The five-year high for Operating Expenses was $2.3 million in Q2 2026, with the low at $613497.0 in Q4 2024.
- Average Operating Expenses over 5 years is $1.3 million, with a median of $1.4 million recorded in 2023.
- The sharpest annual moves came in 2024 and 2026: Operating Expenses tumbled 40.2% in 2024, then jumped 203.29% in 2026.
- Over 5 years, Operating Expenses stood at $1.6 million in 2022, then sank by 37.16% to $1.0 million in 2023, then slumped by 40.2% to $613497.0 in 2024, then soared by 197.4% to $1.8 million in 2025, then advanced by 28.8% to $2.3 million in 2026.
- The last three Operating Expenses figures came in at $2.3 million (Q2 2026), $1.8 million (Q4 2025), and $1.8 million (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 6.54 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 18.20 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 2.09 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 3.00 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | -1.05 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | 960.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 1.06 Bn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 2.60 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | 367.83 Mn |
| 10 | Nomad Power Solutions | 49.59 Mn | 49.59 Mn | - | 2.35 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.35 Mn |
| Dec 31, 2025 | 1.82 Mn |
| Sep 30, 2025 | 1.80 Mn |
| Jun 30, 2025 | 774,809.00 |
| Mar 31, 2025 | 706,940.00 |
| Dec 31, 2024 | 613,497.00 |
| Sep 30, 2024 | 983,257.00 |
| Jun 30, 2024 | 1.01 Mn |
| Mar 31, 2024 | 966,879.00 |
| Dec 31, 2023 | 1.03 Mn |
| Sep 30, 2023 | 1.02 Mn |
| Jun 30, 2023 | 1.67 Mn |
| Mar 31, 2023 | 1.37 Mn |
| Dec 31, 2022 | 1.63 Mn |
| Sep 30, 2022 | 1.48 Mn |
| Jun 30, 2022 | 1.55 Mn |
| Mar 31, 2022 | 1.65 Mn |
| Dec 31, 2021 | 2.02 Mn |
| Sep 30, 2021 | 1.24 Mn |
| Jun 30, 2021 | 1.73 Mn |